Shortage Notice: Provera (medroxyprogesterone acetate) 100mg tablets

Shortage Notice: Provera (medroxyprogesterone acetate) 100mg tablets

September 20, 2019

Pfizer, the sole supplier of Provera tablets, are experiencing manufacturing delays, and are out of stock of the 100mg tablets until week ending 8th November 2019.

Provera 200mg and 400mg tablets remain available, but Pfizer say ‘they are unable to bridge the gap without going out of stock’.

For guidance on alternative agents and management options please see the shortage of supply memo here.

Pharmacy team are reminded that where a prescriber wishes you to dispense an import, prescriptions must be annotated ‘Special Order’. All prescriptions for unlicensed medicines should be placed in the red separators for the end of month submission.

A prescription calling for the unlicensed product should be endorsed as follows:

  • Quantity dispensed
  • Pack size
  • Price per unit less any discount/rebate
  • Manufacturer/importer MHRA license number
  • Batch number
  • Specials procurement fee endorsement of ‘SP’

Click here to see the full communication from Department of Health and Social Care.

See our factsheet for further guidance on endorsing unlicensed specials and imports.

Posted in: ,

More Latest News >

Self Care Week 2019

Self Care Week, which is an annual national awareness week that focuses on providing support for self care across communities and families,...

Final CPCS service spec published

Following its passage through the NHS England and NHS Improvement (NHSE&I) internal governance process, the final version of the Community...

Ask PSNC: Flu FAQs

The services team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2019/20. Below are...


The general NHSmail national helpdesk at NHS Digital has been receiving a number of queries from community pharmacy contractors about...